RIVA-RISEDRONATE

Product Overview

About RIVA-RISEDRONATE

RIVA-RISEDRONATE is a prescription medication containing the active ingredient RISEDRONATE SODIUM (RISEDRONATE SODIUM HEMIPENTAHYDRATE), a bisphosphonate used in the treatment and prevention of osteoporosis in postmenopausal women and men.

Key Benefits & Uses

• Treatment and prevention of osteoporosis in postmenopausal women and men.
• Reduction of the risk of vertebral and non-vertebral fractures in postmenopausal women with osteoporosis.
• Prevention of osteoporosis-related fractures in men with osteoporosis.

Active Ingredient & Action

RISEDRONATE SODIUM (RISEDRONATE SODIUM HEMIPENTAHYDRATE) works by inhibiting osteoclast-mediated bone resorption, thereby increasing bone mass and reducing the risk of fractures. It is a potent inhibitor of bone resorption, which helps to maintain bone density and reduce the risk of osteoporosis-related fractures.

Important Notes

It is essential to follow the recommended dosage and administration instructions provided by your healthcare provider. RIVA-RISEDRONATE may increase the risk of esophageal irritation and ulcers, particularly when taken with other medications that may irritate the esophagus. Patients should be advised to take the medication with a full glass of water and remain upright for at least 30 minutes after administration to minimize the risk of esophageal irritation. Regular monitoring of kidney function and serum calcium levels is recommended, especially in patients with pre-existing kidney disease or hypercalcemia.